Study of Latent Tuberculosis Infection in Health-care Workers and Medical Students at Fondazione Policlinico Universitario A. Gemelli IRCCS
Led by Eleonora Nucera · Updated on 2024-02-13
2040
Participants Needed
1
Research Sites
24 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to understand how common Latent Tuberculosis Infection LTBI is among health care workers and students. LTBI means being infected with Mycobacterium tuberculosis without showing symptoms of active disease. The study also explores possible risk factors for LTBI in a large group of health care workers and students associated with a major hospital and medical school in Rome.
Participants include health care workers from a large tertiary hospital and students from various medical-related degree programs trained at the same hospital. They will complete a brief 9-item multiple-choice questionnaire on a tablet, which explains the studys goals and gathers relevant data. The study is cross-sectional, meaning it captures information at one point in time.
During the study, participants will provide information through the questionnaire, which covers demographics, vaccination history, work exposure, and health background. The key measurement is the prevalence of LTBI, determined using specific tests including the QuantiFERON-TB Gold test and medical evaluation to exclude active tuberculosis. The study collects data on various factors like age, sex, smoking, and medical history, all at enrollment. Participation involves a one-time survey, and the study ends after this data collection.
CONDITIONS
Brief Title
Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students
Research Team
A
Angela Rizzi, MD, PhD
R
Raffaella Chini, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
All health-care workers at Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome
All students in three-year, single-cycle, master's, or graduate medical degree courses trained at the Fondazione Policlinico Universitario A. Gemelli IRCCS
Written informed consent to participate
You will not qualify if you...
Denied informed consent
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - 1 day
Participants complete a questionnaire and undergo diagnostic tests to determine the presence of latent tuberculosis infection.
1 visit (in-person)
Surveillance
Duration - Cross-sectional assessment at enrollment
Participants are observed to assess the prevalence of latent tuberculosis infection and potential risk factors through survey data.
No additional visits required
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Study of 18F-Fibroblast Activation Protein Inhibitor 18F-FAPI-74 PETCT Scans in Adults with Pulmonary Tuberculosis to Detect Lung Fibrosis
Testing a 1-Month Ultra-Short Treatment to Prevent Active Tuberculosis in School Contacts
Comparing 1H3P3 and 3HR Regimens in Adolescents and School Staff
Phase 2b Study Comparing JDB0131 Benzenesulfonate Tablets and Delamanid
in Combination Treatments for Rifampin-Resistant Tuberculosis
Safety and Drug Level Study of Isoniazid Inhalation by Wet Nebulization in Adults with Tuberculosis
Dose Finding and Safety Study of Daily Rifapentine with Isoniazid for Tuberculosis Prevention in Children Under 13 With and Without HIV
Phase 2 Open-label Study of Oral Alpibectir with Ethionamide and with Rifampicin, Pyrazinamide, and Ethambutol in Adults with Newly Diagnosed Drug-Susceptible Pulmonary Tuberculosis
Phase 1 Study of Oral Microgynon and Ganfeborole Interaction in Healthy Non-Childbearing Female Adults Aged 18 to 64 Years
Screening for Tuberculosis in High-Risk Groups Living in Barcelona
Study on Screening for Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients
Comparing Moderate Drinking Advice to Abstention Advice for Adults 50 to 75 Years to Prevent Major Diseases and Death
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
An interoperable web-based platform to support health surveillance against latent tuberculosis infection in health care workers and students: The evolution of CROSSWORD study protocol.